Red blood cell folate and plasma folate are not associated with risk of incident colorectal cancer in the Women's Health Initiative observational study

International Journal of Cancer

Volumn 137, Issue 4, 2015, Pages 930-939

  Neuhouser, Marian L ^a,b   Cheng, Ting Yuan David ^a,b,c   Beresford, Shirley A A ^a,b   Brown, Elissa ^a   Song, Xiaoling ^a   Miller, Joshua W ^d,e   Zheng, Yingye ^a   Thomson, Cynthia A ^f   Shikany, James M ^g   Vitolins, Mara Z ^h   Rohan, Thomas ⁱ   Green, Ralph ^e   Ulrich, Cornelia M ^a,j  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c ROSWELL PARK CANCER INSTITUTE   (United States)

^d RUTGERS UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g University of Alabama at Birmingham   (United States)

^h WAKE FOREST SCHOOL OF MEDICINE   (United States)

ⁱ ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^j UNIVERSITY OF UTAH   (United States)

more..

Author keywords

colorectal cancer; folate; observational studies; postmenopausal women

Indexed keywords

BIOLOGICAL MARKER; FOLIC ACID;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CANCER STAGING; CELL LEVEL; COLORECTAL CANCER; CONTROLLED STUDY; DIET; DISEASE ASSOCIATION; ERYTHROCYTE; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; WOMEN'S HEALTH; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY; PLASMA; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; ERYTHROCYTES; FEMALE; FOLIC ACID; HUMANS; MIDDLE AGED; PLASMA; POSTMENOPAUSE; RISK FACTORS;

EID: 84931564612     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29453     Document Type: Article

References (41)

1. Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for thiamin, riboflavin, niacin, vitamin B6, folate, vitamin B12, pantothenic acid, biotin, and choline. A report of the Standing Committee on the Scientific Evaluation of Dietary Reference Intakes and its Panel on Folate, Other B Vitamins, and Choline and Subcommittee on Upper Reference Levels of Nutrients. Washington, DC: National Academy Press, 1998.
2. Kim YI,. Folate and DNA methylation: a mechanistic link between folate deficiency and colorectal cancer? Cancer Epidemiol Biomarkers Prev 2004; 13: 511-9.
3. Chen JXX, Liu AY, Ulrich CM,. Folate and cancer: epidemiological perspective. In:, Bailey LB, ed. Folate in health and disease, 2nd edn. New York: CRC Press, 2009.
4. Fuchs CS, Willett WC, Colditz GA, et al., The influence of folate and multivitamin use on the familial risk of colon cancer in women. Cancer Epidemiol Biomarkers Prev 2002; 11: 227-34.
5. Meenan J, O'Hallinan E, Scott J, Weir DG,. Epithelial cell folate depletion occurs in neoplastic but not adjacent normal colon mucosa. Gastroenterology 1997; 112: 1163-8.
6. Kim YI, Baik HW, Fawaz K, et al., Effects of folate supplementation on two provisional molecular markers of colon cancer: a prospective, randomized trial. Am J Gastroenterol 2001; 96: 184-95.
7. Sanjoaquin MA, Allen N, Couto E, et al., Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 2005; 113: 825-8.
8. LeMarch L, White KK, Nomura AM, et al., Plasma levels of B vitamins and colorectal cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev 2009; 18: 2195-201.
9. Weinstein SJ, Albanes D, Selhub J, et al., One-carbon metabolism biomarkers and risk of colon and rectal cancers. Cancer Epidemiol Biomarkers Prev 2008; 17: 3233-40.
10. Otani T, Iwasaki M, Sasazuki S, et al., Plasma folate and risk of colorectal cancer in a nested case-control study: the Japan Public Health Center-based prospective study. Cancer Causes Control 2008; 19: 67-74.
11. Eussen SJ, Vollset SE, Igland J, et al., Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010; 19: 1328-40.
12. Anderson GL, Neuhouser ML,. Obesity and the risk for premenopausal and postmenopausal breast cancer. Cancer Prev Res 2012; 5: 515-21.
13. Cole BF, Baron JA, Sandler RS, et al., Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297: 2351-9.
14. Ulrich CM, Potter JD,. Folate supplementation: too much of a good thing? Cancer Epidemiol Biomarkers Prev 2006; 15: 189-93.
15. Mason JB, Dickstein A, Jacques PF, et al., A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev 2007; 16: 1325-9.
16. Logan RF, Grainge MJ, Shepherd VC, et al., Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008; 134: 29-38.
17. Lee JE, Wei EK, Fuchs CS, et al., Plasma folate, methylenetetrahydrofolate reductase (MTHFR), and colorectal cancer risk in three large nested case-control studies. Cancer Causes Control 2012; 23: 537-45.
18. Zschabitz S, Cheng TY, Neuhouser ML, et al., B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative observational study cohort. Am J Clin Nutr 2013; 97: 332-43.
19. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Control Clin Trials 1998; 19: 61-109.
20. Anderson GL, Manson J, Wallace R, et al., Implementation of the Women's Health Initiative study design. Ann Epidemiol 2003; 13: S5-17.
21. Patterson RE, White E, Kristal AR, et al., Vitamin supplements and cancer risk: the epidemiologic evidence. Cancer Causes Control 1997; 8: 786-802.
22. Kim YI,. Folic acid fortification and supplementation-good for some but not so good for others. Nutr Rev 2007; 65: 504-11.
23. Williams LJ, Rasmussen SA, Flores A, et al., Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics 2005; 116: 580-6.
24. Vollset SE, Clarke R, Lewington S, et al., Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 2013; 381: 1029-36.
25. Giovannucci E, Stampfer MJ, Colditz GA, et al., Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998; 129: 517-24.
26. Giovannucci E, Stampfer MJ, Colditz GA, et al., Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 1993; 85: 875-84.
27. Kim DH, Smith-Warner SA, Spiegelman D, et al., Pooled analyses of 13 prospective cohort studies on folate intake and colon cancer. Cancer Causes Control 2010; 21: 1919-30.
28. World Cancer Research Fund/American Institute for Cancer Research. Food, nutrition, physical activity, and the prevention of cancer: a global perspective. Washington, DC: American Institute for Cancer Research; 2007.
29. Reed MC, Nijhout HF, Neuhouser ML, et al., A mathematical model gives insights into nutritional and genetic aspects of folate-mediated one-carbon metabolism. J Nutr 2006; 136: 2653-61.
30. Neuhouser ML, Nijhout HF, Gregory JF, 3rd, et al., Mathematical modeling predicts the effect of folate deficiency and excess on cancer-related biomarkers. Cancer Epidemiol Biomarkers Prev 2011; 20: 1912-7.
31. Ulrich CM, Neuhouser M, Liu AY, et al., Mathematical modeling of folate metabolism: predicted effects of genetic polymorphisms on mechanisms and biomarkers relevant to carcinogenesis. Cancer Epidemiol Biomarkers Prev 2008; 17: 1822-31.
32. Gibson TM, Weinstein SJ, Pfeiffer RM, et al., Pre- and postfortification intake of folate and risk of colorectal cancer in a large prospective cohort study in the United States. Am J Clin Nutr 2011; 94: 1053-62. Oct
33. Nan H, Lee JE, Rimm EB, et al., Prospective study of alcohol consumption and the risk of colorectal cancer before and after folic acid fortification in the United States. Ann Epidemiol 2013; 23: 558-63.
34. Neuhouser ML, Tinker L, Shaw PA, et al., Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. Am J Epidemiol 2008; 167: 1247-59.
35. Song J, Medline A, Mason JB, et al., Effects of dietary folate on intestinal tumourigenesis in the ApcMin mouse. Cancer Res 2000; 60: 5434-30.
36. Song J, Sohn KJ, Medline A, et al., Chemopreventive effects of dietary folate on intestinal polyps in Apc+/-Msh2-/- mice. Cancer Res 2000; 60: 3191-9.
37. Troen AM, Mitchell B, Sorensen B, et al., Unmetabolized folic acid in plasma is associated with reduced natural killer cell cytotoxicity among postmenopausal women. J Nutr 2006; 136: 189-94.
38. Luebeck EG, Moolgavkar SH, Liu AY, et al., Does folic acid supplementation prevent or promote colorectal cancer? Results from model-based predictions. Cancer Epidemiol Biomarkers Prev 2008; 17: 1360-7.
39. Keum N, Giovannucci EL,. Folic acid fortification and colorectal cancer risk. Am J Prev Med 2014; 46: S65-72.
40. Lucock M, Yates Z,. Folic acid fortification: a double-edged sword. Curr Opin Clin Nutr Metab Care 2009; 12: 555-64.
41. Delgado-Plasencia L, Medina-Arana V, Bravo-Gutierrez A, et al., Impact of the MTHFR C677T polymorphism on colorectal cancer in a population with low genetic variability. Int J Colorectal Dis 2013; 28: 1187-93.